RenovoRx
RNXT
8 hedge funds and large institutions have $1.02M invested in RenovoRx in 2021 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
2.02% more ownership
Funds ownership: 0% → 2.02% (+2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University
Redwood City,
California
|
+$507K |
| 2 |
Cambridge Investment Research Advisors
Fairfield,
Iowa
|
+$340K |
| 3 |
SSA
Schonfeld Strategic Advisors
New York
|
+$171K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$149K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$100K |
Top Sellers
RNXT Hedge Fund Activity: Q3 2021 in Review
8 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in RenovoRx (RNXT) for Q3 2021, worth a combined $1.02M.
Buyers outnumbered sellers: 8 funds opened new RNXT positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Board of Trustees of The Leland Stanford Junior University, opening a new position worth an estimated $507K.
- 8 institutional investors held RenovoRx (RNXT) as of Q3 2021, up from 0 in Q2 2021.
- Funds reported $1.02M of RenovoRx stock for Q3 2021.
- 8 funds opened new RenovoRx positions in Q3 2021 and 0 closed out, a net change of +8 holders.
- The largest RenovoRx buyer in Q3 2021 was Board of Trustees of The Leland Stanford Junior University, an estimated $507K added.
Based on aggregated 13F filings for Q3 2021.